Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -129,766 | -127,499 | -89,218 | -66,221 | -48,625 |
| Depreciation Amortization | 2,866 | 4,108 | 5,361 | 5,137 | 3,328 |
| Accounts payable and accrued liabilities | -3,011 | 1,994 | -52 | 528 | 10 |
| Other Working Capital | -18,178 | 5,054 | 17,606 | -10,230 | -5,896 |
| Other Operating Activity | 12,770 | 5,521 | 4,945 | 4,283 | 2,506 |
| Operating Cash Flow | $-135,319 | $-110,822 | $-61,358 | $-66,503 | $-48,677 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,407 | -3,825 | -3,146 | -4,225 | -9,941 |
| Purchase Of Investment | -87,471 | -241,445 | -77,613 | N/A | N/A |
| Sale Of Investment | 201,250 | 192,657 | 20,000 | N/A | N/A |
| Investing Cash Flow | $109,372 | $-52,613 | $-60,759 | $-4,225 | $-9,941 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 32,457 | N/A | 29,354 | N/A |
| Debt Repayment | N/A | -17,144 | N/A | N/A | N/A |
| Common Stock Issued | 264 | 193,452 | 135,443 | 326 | 89,938 |
| Other Financing Activity | -600 | 0 | 0 | -324 | 99,730 |
| Financing Cash Flow | $-336 | $208,765 | $135,443 | $29,356 | $189,668 |
| Beginning Cash Position | 183,720 | 138,390 | 125,064 | 166,436 | 35,386 |
| End Cash Position | 157,437 | 183,720 | 138,390 | 125,064 | 166,436 |
| Net Cash Flow | $-26,283 | $45,330 | $13,326 | $-41,372 | $131,050 |
| Free Cash Flow | |||||
| Operating Cash Flow | -135,319 | -110,822 | -61,358 | -66,503 | -48,677 |
| Capital Expenditure | -4,407 | -3,825 | -3,146 | -4,225 | -9,941 |
| Free Cash Flow | -139,726 | -114,647 | -64,504 | -70,728 | -58,618 |